SAMHSA logoFY 2005 Grant Funding Opportunity

   

 

Downloadable files

  

Application Information:

Center for Substance Abuse Prevention (CSAP)
 

Request for Applications (RFA) MODIFICATION
 

Download RFA

SP-05-001:

 

Substance Abuse (SA), HIV, & Hepatitis Prevention for Minority Populations and Minority Reentry Populations in Communities of Color [MOD]

 Short Title: Minority SA/HIV/Hep Strategic Prevention Framework (SPF)  
 

Word Document

Acrobat Document

Request for Applications (RFA) No. SP-05-001

Grants.gov Notice: January 13, 2005

Receipt date:  March 17, 2005, with exception noted in Modification information (see below)

Announcement Type:  Initial

 
    Catalogue of Federal Domestic Assistance (CFDA) No.: 93.243
 
Scroll down for more links

Key Dates:

Application Deadline

This is a modification of RFA SP-05-001, published on January 13, 2005.  This modification corrects the list of eligible States for this funding opportunity (contained in Appendix B of the RFA) to include Puerto Rico and the Virgin Islands, which were inadvertently left off of the list published on January 13, 2005. 

Applications for SP-05-001 are due on March 17, 2005.  However, this application deadline is extended to April 14, 2005, for the two eligible States (Puerto Rico and the Virgin Islands ) that were not included in the original publication of SP-05-001.  This extended deadline applies only to Puerto Rico and the Virgin Islands .

Intergovernmental Review

(E.O. 12372)

Letters from State Single Point of Contact (SPOC) are due no later than 60 days after application deadline.

Public Health System Impact Statement (PHSIS)/Single State Agency Coordination

Applicants must send the PHSIS to appropriate State and local health agencies by application deadline. Comments from Single State Agency are due no later than 60 days after application deadline.

 

As authorized under Section 516 of the Public Health Service Act, the Substance Abuse and Mental Health Services Administration (SAMHSA) Center for Substance Abuse Prevention (CSAP) announces the availability of funds for its Substance Abuse (SA), HIV, & Hepatitis Prevention for Minority Populations and Minority Reentry Populations in Communities of Color Initiative.

This initiative supports an array of activities to assist grantees in building a solid foundation for delivering and sustaining effective substance abuse prevention and related services.  Specifically, the program aims to engage community-level domestic public and private non-profit entities to prevent and reduce the onset of SA, and transmission of HIV and hepatitis among minority populations and minority reentry populations in communities of color disproportionately affected by SA, HIV/AIDS, and/or hepatitis.

While grantees will have substantial flexibility in designing their grant projects, all are required to base their projects on the five steps of SAMHSA’s Strategic Prevention Framework (SPF) to build a service capacity specific to SA, HIV, and hepatitis prevention services. 

Eligibility

Eligible applicants are community-level domestic public and private nonprofit entities.  For example, non-profit community-based organizations, faith-based organizations, colleges and universities, health care delivery organizations, local governments, tribal governments, tribal organizations and tribal urban Indian entities are eligible to apply. Since the purpose of this RFA is to expand the capacity of community-level domestic public and private non-profit entities, State and national organizations are not eligible to apply.

Eligibility is limited to applicants from geographic areas with high AIDS case rates.  Only applicants located in, or in close proximity to and proposing to provide services in, one of the following are eligible to apply:

a) Geographic areas within States with an annual AIDS case rate of at least 10 cases per 100,000 people.

b) Metropolitan Statistical Areas (MSAs) with an annual AIDS case rate of at least 20 cases per 100,000 people among minority populations.

See Appendix B of the RFA document for a list of States and MSAs that meet the above criteria based on data from the Centers for Disease Control and Prevention (CDC).

See RFA for additional eligibility requirements.

Additional Information

It is expected that a total of $20.6 million will be available to fund 59-82 awards in fiscal year 2005.  The average annual award will range from $250,000-$350,000 per year in total costs (direct and indirect).   The maximum allowable award is $350,000 in total costs (direct and indirect) per year for up to 5 years.   Proposed budgets cannot exceed the allowable amount in any year of the proposed project.

Cost sharing is not required.

Funding mechanism is cooperative agreement.

For questions on program issues, contact:

Claudia Richards, M. S. W.

Chief, HIV & Behavioral Health Issues Branch

Division of Knowledge Application and Systems Improvement

Center for Substance Abuse Prevention, SAMHSA 

1 Choke Cherry Road

Rockville, MD 20857

Work:  (240) 276-2400

Technical Assistance:  (240) 276-2409

E-Mail: rhti@samhsa.gov

For questions on grants management issues, contact:

Kimberly Pendleton

Office of Program Services, Division of Grants Management       

Substance Abuse and Mental Health Services Administration

1 Choke Cherry Road

Room 7-1097

Rockville, Maryland 20857

(240) 276-1421

E-Mail: kimberly.pendleton@samhsa.hhs.gov

 

Documents needed to complete an application for this grant opportunity:

Download RFA:

   The complete Request for Applications (RFA) No. SP-05-001MOD
Download forms:
 

PHS 5161-1 (revised July 2000): Includes the face page, budget forms, assurances, certification,  and checklist.

Applications that are not submitted on the required application form will be screened out and will not be reviewed.

Additional Materials:

 

For further information on the forms and the application process, see Useful Information for Applicants

Additional materials available on this website include:

 
 
 

For a complete application kit, call the National Clearinghouse for Alcohol and Drug Information (NCADI): 

  • 800-729-6686

  • 800-487-4889 TDD